- Wealth
- ₹8,900 Cr
- Company
- Transasia Bio-Medicals
About Suresh Hassanand Vazirani
Data last updated:
Suresh Hassanand Vazirani is a Director at Transasia Bio-Medicals Limited (since 2008), Director at Transasia Diagnostics Private Limited (since 2020) and Director at Vazirani Properties Private Limited (since 1999), and holds 5 more current directorships. The companies operate in Healthcare, Real Estate and Construction and Business Services. The 7 current companies with reported revenue have a combined latest revenue of ₹1,687 Cr; the largest is Transasia Bio-Medicals Limited at ₹1,450 Cr (FY 2025). Earlier, Suresh Hassanand Vazirani was a Director at Sysmex India Private Limited (1998–2008) and Managing Director at Sysmex Transasia Services Private Limited (from 2009).
Suresh H Vazirani and family are #416 among India's richest people (2026), with wealth of ₹8,900 Cr.
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2008 | 1985 | ₹1,450 Cr (FY 2025) | Active | |
| Director | 26 Aug 2020 | 2020 | ₹81.93 Cr (FY 2025) | Active | |
| Director | 25 Jun 1999 | 1999 | ₹77.09 Cr (FY 2025) | Active | |
| Director | 25 Sep 2020 | 2020 | ₹76.96 Cr (FY 2025) | Active | |
| Director | 10 Apr 2019 | 2019 | ₹39 Lakh (FY 2025) | Active | |
| Director | 03 May 2017 | 2017 | ₹13.5 Lakh (FY 2025) | Active | |
| Director | 01 Jun 2007 | 2003 | ₹3,640 (FY 2023) | Active | |
| Director | 20 Apr 1988 | 1988 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jul 1998 | 1998 | ₹315 Cr (FY 2022) | Active | |
| Managing Director | 04 Mar 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Suresh Hassanand Vazirani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Hassanand Vazirani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Hassanand Vazirani
Suresh Hassanand Vazirani currently holds 8 directorships: Transasia Bio-Medicals Limited (Director, since 01 Apr 2008, revenue ₹1,450 Cr (FY 2025)); Transasia Diagnostics Private Limited (Director, since 26 Aug 2020, revenue ₹81.93 Cr (FY 2025)); Vazirani Properties Private Limited (Director, since 25 Jun 1999, revenue ₹77.09 Cr (FY 2025)); Vazirani Realty Private Limited (Director, since 25 Sep 2020, revenue ₹76.96 Cr (FY 2025)); Transasia Diagnostics Solutions Limited (Director, since 10 Apr 2019, revenue ₹39 Lakh (FY 2025)); and 3 more.
Suresh Hassanand Vazirani was first appointed on 20 Apr 1988 as Director at Transasia Instruments Limited. The most recent appointment on record is 25 Sep 2020 at Vazirani Realty Private Limited.
The 7 current companies of Suresh Hassanand Vazirani that report revenue have a combined latest revenue of ₹1,687 Cr: Transasia Bio-Medicals Limited ₹1,450 Cr (FY 2025); Transasia Diagnostics Private Limited ₹81.93 Cr (FY 2025); Vazirani Properties Private Limited ₹77.09 Cr (FY 2025); Vazirani Realty Private Limited ₹76.96 Cr (FY 2025); Transasia Diagnostics Solutions Limited ₹39 Lakh (FY 2025); and 2 more.
Suresh Hassanand Vazirani held 2 earlier board appointments: Sysmex India Private Limited (Director, 23 Jul 1998 to 11 Dec 2008); Sysmex Transasia Services Private Limited (Managing Director, from 04 Mar 2009).
The current boards of Suresh Hassanand Vazirani's companies include Aditi Pradeep Pai (Transasia Bio-Medicals Limited), Ashok Kanwarlal Suthar (Transasia Bio-Medicals Limited), Mala Suresh Vazirani (Transasia Bio-Medicals Limited), Nikhil Kumar Suresh Vazirani (Transasia Bio-Medicals Limited), Nishant Saxena (Transasia Bio-Medicals Limited), Rajendra Vadilal Gandhi (Transasia Bio-Medicals Limited), among others.